Related MeSH Hierarchy (5)
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Leukemia » Leukemia, Myeloid » Leukemia, Myelogenous, Chronic, BCR-ABL Positive » Blast Crisis
Diseases [C] » Neoplasms [C04] » Neoplastic Processes » Carcinogenesis » Cell Transformation, Neoplastic » Blast Crisis
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Bone Marrow Diseases » Myeloproliferative Disorders » Leukemia, Myelogenous, Chronic, BCR-ABL Positive » Blast Crisis
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Neoplastic Processes » Carcinogenesis » Cell Transformation, Neoplastic » Blast Crisis
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Disease Attributes » Chronic Disease » Leukemia, Myelogenous, Chronic, BCR-ABL Positive » Blast Crisis
Description
An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%. MeSH
Hierarchy View
Phase 2 Indicated Drugs (7)
Phase 1 Indicated Drugs (2)
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 2 Indications (49)
Icahn School of Medicine at Mount Sinai
Innovative Therapies For Children with Cancer Consortium
Myeloproliferative Neoplasms Research Consortium
National Cancer Institute (NCI)
Organization Involved with Phase 1 Indications (17)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.